GlassScriptPhysician profile
Edward A Gill
NPI 1518046275
$96,170.34
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $18K · 2021: $3,000 · 2022: $15K · 2023: $12K · 2024: $12K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,500 · Travel and Lodging: $7,014 · Food and Beverage: $2,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $17,900.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,500.00 |
| Travel and Lodging | $7,013.98 |
| Food and Beverage | $2,173.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $91,829.25 | 2019-2025 | Clinical Educ Ultrasound, (1658) Clinical Educ Ultrasound, (1658) Clin Educ US |
| Edwards Lifesciences Corporation | $2,918.32 | 2019-2025 | Evoque, Pascal |
| Abbott Laboratories | $306.01 | 2024-2025 | Mitraclip, Triclip |
| Amgen INC. | $237.76 | 2024-2025 | Repatha |
| Boston Scientific Corporation | $210.10 | 2019-2024 | Watchman Flx, Watchman |
| Kaneka Medical America LLC | $209.65 | 2024 | |
| Sanofi-Aventis U.S. LLC | $146.17 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $102.25 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $99.11 | 2023 | Praluent, Evkeeza |
| E.R. Squibb & Sons, L.L.C. | $77.32 | 2023 | Camzyos |
| Medtronic, INC. | $17.23 | 2023 | Corevalve Evolut R |
| Angiodynamics, INC. | $17.17 | 2025 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.